메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Choi, Yun-Jung (Department of Nuclear Medicine, Yonsei University Health System) Cho, Byoung Chul (Department of Internal Medicine, Yonsei University Health System) Jeong, Yong Hyu (Department of Nuclear Medicine, Yonsei University Health System) Seo, Hyo Jung (Department of Nuclear Medicine, Yonsei University Health System) Kim, Hyun Jeong (Department of Nuclear Medicine, Yonsei University Health System) Cho, Arthur (Department of Nuclear Medicine, Yonsei University Health System) Lee, Jae Hoon (Department of Nuclear Medicine, Yonsei University Health System) Yun, Mijin (Department of Nuclear Medicine, Yonsei University Health System) Jeon, Tae Joo (Department of Nuclear Medicine, Yonsei University Health System) Lee, Jong Doo (Department of Nuclear Medicine, Yonsei University Health System) Kang, Won Jun (Department of Nuclear Medicine, Yonsei University Health System)
저널정보
대한핵의학회 Nuclear medicine and molecular imaging : NMMI Nuclear medicine and molecular imaging : NMMI 제46권 제3호
발행연도
2012.1
수록면
169 - 175 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose Mutations in the epidermal growth factor receptor (EGFR) gene have been identified as potential targets for the treatment and prognostic factors for non-small cell lung cancer (NSCLC). We assessed the correlation between fluorodeoxyglucose (FDG) uptake and EGFR mutations, as well as their prognostic implications. Methods A total of 163 patients with pathologically confirmed NSCLC were enrolled (99 males and 64 females; median age, 60 years). All patients underwent FDG positron emission tomography before treatment, and genetic studies of EGFR mutations were performed. The maximum standardized uptake value (SUVmax) of the primary lung cancer was measured and normalized with regard to liver uptake. The SUVmax between the wild-type and EGFR mutant groups was compared. Survival was evaluated according to SUVmax and EGFR mutation status. Results EGFR mutations were found in 57 patients (60.8 %). The SUVmax tended to be higher in wild-type than mutant tumors, but was not significantly different ($11.1{\pm}5.7$ vs. $9.8{\pm}4.4$, P=0.103). The SUVmax was significantly lower in patients with an exon 19 mutation than in those with either an exon 21 mutation or wild type (P=0.003 and 0.009, respectively). The EGFR mutation showed prolonged overall survival (OS) compared to wild-type tumors (P=0.004). There was no significant difference in survival according to SUVmax. Both OS and progression-free survival of patients with a mutation in exon 19 were significant longer than in patients with wild-type tumors. Conclusion In patients with NSCLC, a mutation in exon 19 was associated with a lower SUVmax and is a reliable predictor for good survival.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0